Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Features

Vigilance and Planning Are Necessary in Bankruptcy Matters Image

Vigilance and Planning Are Necessary in Bankruptcy Matters

Raymond J. Werner

Two recent decisions by the U.S. Court of Appeals for the Seventh Circuit have attracted the attention of leasing lawyers. Both of those cases demonstrate that landlords and tenants alike may be taken by surprise by the operation of the Bankruptcy Code.

The Evolution of a Lease Provision: Sublease and Assignment Image

The Evolution of a Lease Provision: Sublease and Assignment

Myles Hannan & Gina A. Leib

In the absence of a lease provision restricting subleasing and assignment, common law permits a tenant to freely sublease its leased premises or assign its leasehold interest in the leased premises. In order to provide for maximum landlord control over a tenant's ability to sublease or assign its leasehold interest, while at the same time balancing the need of tenants for an exit strategy, modern forms of leases contain extensive assignment and sublease provisions. This article traces the manner in which those provisions have evolved over the years.

Features

New Pharmaceutical Agreement Notification Filing Requirements Image

New Pharmaceutical Agreement Notification Filing Requirements

ALM Staff & Law Journal Newsletters

As of Jan. 7, 2004, pursuant to Section 1112 of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, agreements between brand-name and generic pharmaceutical companies regarding the manufacture, marketing, and sale of generic versions of brand-name drug products are required to be filed with the Federal Trade Commission and the U.S. Department of Justice.

Features

Case Briefing Image

Case Briefing

ALM Staff & Law Journal Newsletters

Recent rulings of importance to your practice.

Features

Risk Assessment and Post-Market Programs Image

Risk Assessment and Post-Market Programs

Roseann B. Termini

How do the medical device industry and the FDA prevent risks to the end user once the product is marketed? There is no simple answer to this question. Post-market vigilance in terms of risk assessment involves complex issues. These issues involve a cost/benefit analysis in terms of a "best approach" to post-market co-vigilence.

Features

FDA Cannot Force an Over-the-Counter Drug Switch Image

FDA Cannot Force an Over-the-Counter Drug Switch

Andrew S. Krulwich

Does the Food and Drug Administration have authority to force manufacturers of prescription drug products to switch those products to over-the-counter (OTC) distribution against their will? The FDA is currently grappling with this issue, a dispute that has generated substantial controversy, including statements by FDA officials and coverage in leading newspapers.

Pennsylvania Remains a <i>Frye</i> State Image

Pennsylvania Remains a <i>Frye</i> State

ALM Staff & Law Journal Newsletters

Chief Justice Ralph J. Cappy of Pennsylvania's Supreme Court issued an opinion on Dec. 31, 2003, declaring that the State of Pennsylvania would remain a "<i>Frye</i> state" and would not follow suit with much of the rest of the nation in using the <i>Daubert</i> test to qualify expert witnesses.

News from the FDA Image

News from the FDA

ALM Staff & Law Journal Newsletters

The latest information from the Agency.

The Bankruptcy Hotline Image

The Bankruptcy Hotline

ALM Staff & Law Journal Newsletters

Recent rulings of importance to you and your practice.

Features

What Should You Know About the Rules of Evidence? Image

What Should You Know About the Rules of Evidence?

Marc Bennett

Bankruptcy lawyers who rarely visit a courtroom may think they do not need to worry about the rules of evidence. Yet evidentiary rules can provide critical protections. In a typical case or negotiation, lawyers create and circulate tremendous amounts of information -- much of which would be potentially damaging if obtained by other parties. To protect this information, bankruptcy lawyers need to be familiar with the rules of evidence and how courts have interpreted these rules.

Need Help?

  1. Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
  2. Need other assistance? email Customer Service or call 1-877-256-2472.

MOST POPULAR STORIES